Olmesartan and drug-induced enteropathy

P and T

Volumn 39, Issue 1, 2014, Pages 47-50

  Tran, Tran H ^a   Li, Hanlin ^a,b  

^a ST JOHN'S UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS HYDROCHLOROTHIAZIDE PLUS OLMESARTAN; AMLODIPINE PLUS OLMESARTAN; ANGIOTENSIN II; HYDROCHLOROTHIAZIDE PLUS OLMESARTAN; OLMESARTAN;

ABDOMINAL PAIN; AGED; CAPSULE ENDOSCOPY; CASE REPORT; CELIAC DISEASE; CELLULAR IMMUNITY; DIARRHEA; DRUG INDUCED ENTEROPATHY; DRUG WITHDRAWAL; ENDOSCOPIC BIOPSY; ENTEROPATHY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERPLASIA; HYPERTENSION; MALE; NOTE; WEIGHT REDUCTION;

EID: 84892491319     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. Ludvigsson JF, Leffer DA, Bai JC, et al. The Oslo defnitions for coeliac disease and related terms. Gut 2013;62(1):43-52.
2. Ziegler TR, Fernández-Estívariz C, Gu LH, et al. Severe villus atrophy and chronic malabsorption induced by azathioprine. Gastroenterology 2003;124(7):1950-1957.
3. Kamar N, Faure P, Dupuis E. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transpl Int 2004;17(8):463-467.
4. Boscá MM, Añón R, Mayordomo E, et al. Methotrexate induced sprue-like syndrome. World J Gastroenterol 2008; 14(45):7009-7011.
5. Ratnaike RN, Jones TE. Mechanisms of drug-induced diarrhoea in the elderly. Drugs Aging 1998;13(3):245-253.
6. Weclawiak H, Ould-Mohamed A, Bour-net B. Duodenal villous atrophy: A cause of chronic diarrhea after solid-organ transplantation. Am J Transplant 2011;11(3):575-582.
7. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012;87(8):732-738.
8. DeGaetani M, Tennyson CA, Lebwohl B, et al. Villous atrophy and negative celiac serology: A diagnostic and therapeutic dilemma. Am J Gastroenterol 2013;108(5):647-653.
9. Dreifuss SE, Tomizawa Y, Farber NJ, et al. Spruelike enteropathy associated with olmesartan: An unusual case of severe diarrhea. Case Rep Gastrointest Med, March 13, 2013 (online).
10. FDA. Benicar (olmesartan), April 25, 2002. Available at: www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-286_ Benicar_Approv.pdf. Accessed November 20, 2013.
11. Dana WJ, Fuller MA, Goldman M, et al. Drug Information Handbook: A Comprehensive Resource for All Clinicians and Healthcare Professionals, 22nd ed. Hudson, Ohio: Lexi-Comp, 2013.
12. FDA approves label changes to include intestinal problems (sprue-like enteropa-thy) linked to blood pressure medicine olmesartan medoxomil, July 3, 2013. Available at: www.fda.gov/Drugs/Drug-Safety/ucm359477.htm. Accessed September 1, 2013.
13. IMS, Vector One: National (VONA) and Total Patient Tracker (TPT) Database. Year 2012. Extracted June 2013.
14. Stanich P P, Yearsley M, Meyer MM. Olmesartan-associated sprue-like en-ropathy. J Clin Gastroenterol 2013; 47(10):894-895.
15. Herman M, Rubio-Tapia A, Marietta E, Wu T-T, Murray J. Severe enteropathy in a patient on valsartan (Abstract 1013). Am J Gastroenterol 2013;108(Suppl 1). n